Nuvectis Pharma (NVCT) Q3 2025 Earnings

5AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.35
-0.31
-0.28
-0.24

Details

Expected EPS
-0.251667
Actual EPS
-0.3
Surprise EPS
-0.05
Surprise Percent
+19.21%

Description

Nuvectis Pharma (NVCT) has reported earnings of -0.3 per share for Q3 2025.

0 Comments

Share your thoughts